The historic rise of Viagra has long been a benchmark of pharmaceutical success, but its legacy within the broader market now triggers questions about long-term gains. Copycat versions are eroding patent protection , prompting anxieties that supporting companies heavily reliant to Viagra's previous position could be a dangerous strategy, especia… Read More